Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol

被引：94
|
作者：
Xu, Dong [1 ]
Lu, Qinghua [1 ]
Hu, Xun [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affliated Hosp 2, Inst Canc, Hangzhou 310009, Zhejiang Prov, Peoples R China
来源：
CANCER LETTERS | 2006年 / 243卷 / 02期
关键词：
honokiol; P-glycoprotein; drug resistance;
D O I：
10.1016/j.canlet.2005.11.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-glycoprotein accounts for the most intrinsic and acquired cancer multidrug resistance. To inhibit the expression of P-glycoprotein is one of the effective ways to reverse cancer drug resistance. Honokiol, a naturally occurring compound, has been demonstrated to combat cancer through mechanisms including inhibition of angiogenesis and induction of apoptosis. Here, we show that honokiol down-regulated the expression of P-glycoprotein at mRNA and protein levels in MCF-7/ADR, a human breast MDR cancer cell line. The down-regulation of P-glycoprotein was accompanied with a partial recovery of the intracellular drug accumulation, and of the sensitivities toward adriamycin. This study reveals a novel function of honokiol as an anti-cancer agent. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：274 / 280
页数：7
相关论文
共 50 条
  • [1] Triptolide reverses MCF-7/ADR cell resistance by down-regulating P-glycoprotein expression
    Zhang, Pu-Rong
    Zhang, Jian-Hui
    Yu, Miao
    Zhang, Xin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1513 - 1521
  • [2] Metformin Inhibits P-Glycoprotein Expression in Breast Cancer Cell MCF-7/ADR via Inhibition of NF-kB Activation
    Thi, Hien Tran
    Kim, Hyung Gyun
    Jeong, Hye Gwang
    DRUG METABOLISM REVIEWS, 2009, 41 : 43 - 43
  • [3] Rational design of phenyl thiophene (pyridine) derivatives that overcome P-glycoprotein mediated MDR in MCF-7/ADR cell
    Li, Ya-Sheng
    Mao, Shen
    Zhao, Dong-Sheng
    Wang, Can-Can
    Zu, Dan
    Yang, Xi
    Liu, Gui-Jun
    Wang, Si-Jia
    Zhang, Bo
    Bao, Xiao-Ze
    Ye, Xin-Yi
    Wei, Bin
    Cui, Zi-Ning
    Chen, Jian-Wei
    Wang, Hong
    BIOORGANIC CHEMISTRY, 2021, 114
  • [4] REVERSION OF MULTIDRUG RESISTANCE IN THE P-GLYCOPROTEIN POSITIVE BREAST CANCER CELL LINE(MCF-7/ADR) BY INTRODUCTION OF HAMMERHEAD RIBOZYME
    袁亚维
    张积仁
    陆长德
    祁国荣
    Chinese Medical Sciences Journal, 1998, (01) : 24 - 28
  • [5] Lack of competition of substrates for p-glycoprotein in MCF-7 breast cancer cells overexpressing MDR1
    Hall, JG
    Cory, AH
    Cory, JG
    ADVANCES IN ENZYME REGULATION, VOL 39, 1999, 39 : 113 - 128
  • [6] Dolichyl phosphate dependent P-glycoprotein expression in Doxorubicin resistant MCF-7 breast cancer cells
    Kuznecovs, I.
    Kuznecovs, S.
    Jegina, K.
    Kuznecova, G.
    EJC SUPPLEMENTS, 2008, 6 (09): : 86 - 86
  • [7] EFFECT OF P-GLYCOPROTEIN EXPRESSION ON SENSITIVITY TO HORMONES IN MCF-7 HUMAN BREAST-CANCER CELLS
    CLARKE, R
    CURRIER, S
    KAPLAN, O
    LOVELACE, E
    BOULAY, V
    GOTTESMAN, MM
    DICKSON, RB
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (19) : 1506 - 1512
  • [8] Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1
    Wang, Changyuan
    Huo, Xiaokui
    Wang, Lijuan
    Meng, Qiang
    Liu, Zhihao
    Liu, Qi
    Sun, Huijun
    Sun, Pengyuan
    Peng, Jinyong
    Liu, Kexin
    SCIENTIFIC REPORTS, 2016, 6
  • [9] Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1
    Changyuan Wang
    Xiaokui Huo
    Lijuan Wang
    Qiang Meng
    Zhihao Liu
    Qi Liu
    Huijun Sun
    Pengyuan Sun
    Jinyong Peng
    Kexin Liu
    Scientific Reports, 6
  • [10] ALLOSTERIC REGULATION OF [H-3] VINBLASTINE BINDING TO P-GLYCOPROTEIN OF MCF-7 ADR CELLS BY DEXNIGULDIPINE
    FERRY, DR
    MALKHANDI, PJ
    RUSSELL, MA
    KERR, DJ
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (12) : 1851 - 1861
12345